Devastating toll of migraine

Some 60 per cent of chronic migraine sufferers feel disabled by the condition, 76 per cent feel frustrated missing out on quality time with family and friends and 49 per cent say that it has held them back at work. These are the findings of a new survey from pharmaceutical company Allergan, in partnership with the European Migraine Headache Alliance (EMHA).

The results also highlight the urgent need for better migraine awareness in the UK as 84 per cent of respondents feel that people dismissed their migraines as “just headaches” and 89 per cent feel that people did not understand the severity of a migraine attack. 

Richard Leaback, Allergan’s medical affairs director, UK, stated, “Allergan has been involved in chronic migraine research for over 20 years and it’s our hope that we can use these findings to champion better education and improved care options, so patients feel empowered to speak to their doctors about all the treatments that are available to them.”

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Training Matters's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.